Edyta GLOGOWSKA | Cell Metabolism | Best Researcher Award

Dr. Edyta Glogowska | Cell Metabolism | Best Researcher Award

Dr.  Edyta Glogowska, CNRS-IPMC-UniCA,  France.

Dr. Edyta Glogowska is a passionate and accomplished biomedical researcher with a strong academic background in biotechnology and life sciences. From her early beginnings in dental engineering to earning a PhD in red blood cell physiology from the University Pierre and Marie Curie, her academic journey reflects a deep commitment to advancing human health through science. Her postdoctoral research at the Institute of Molecular and Cellular Pharmacology (IPMC) highlights her expertise in cell physiology, electrophysiology, and molecular biology, with a special focus on macrophage Piezo1 channels and their role in atherosclerosis. She is a skilled communicator and team collaborator, recognized for her academic excellence and contributions to hematology and immunopathology.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Edyta Glogowska’s journey into the world of life sciences began with a strong foundation in biotechnology and medical sciences. She earned her Master of Engineering in Biotechnology Processing from Wroclaw University of Science and Technology, where she graduated with highest honors. Even earlier, she had already laid a unique cornerstone for her biomedical interests through specialized training as a Dental Engineer at the Marie Curie Medical Vocational School. Her pursuit of deeper scientific knowledge led her to France, where she undertook her PhD in Biological and Life Sciences at the University Pierre and Marie Curie, Paris VI. Conducted at the prestigious Station Biologique in Roscoff, her doctoral research focused on red blood cell physiology and was awarded with the highest honors—a testament to her early dedication and scientific promise.

🔬 Professional Endeavors

Dr. Glogowska’s professional career has been marked by a steadfast commitment to cell and molecular biology, electrophysiology, and the biochemistry of proteins. Her postdoctoral research at the Institute of Molecular and Cellular Pharmacology (IPMC) in Sophia Antipolis (2021–2024) showcases her hands-on expertise with mice experimentation and patch-clamp techniques, placing her at the cutting edge of biomedical research. Working under the guidance of Dr. Eric Honoré, she explored the role of macrophage Piezo1 channels regulated by lipids, a study with far-reaching implications in understanding and potentially treating atherosclerosis.

🧬 Contributions and Research Focus

Throughout her academic and postdoctoral years, Dr. Glogowska has focused her research on the physiology and pathophysiology of cells, particularly red blood cells and immune cells like macrophages. Her interest lies in understanding how cellular mechanisms contribute to broader medical conditions, such as cardiovascular diseases. By integrating electrophysiology with molecular biology, she brings a comprehensive approach to biomedical questions, bridging the gap between basic research and therapeutic application. Her work on Piezo1 not only contributes to our understanding of mechanotransduction in macrophages but also holds promise for future translational research.

🏅 Accolades and Recognition

Dr. Glogowska’s scholarly excellence has been consistently recognized. She graduated with highest honors both for her Master’s and PhD degrees, a rare academic distinction that underscores her dedication and intellectual rigor. She has also been an active member of the French Society of Hematology, aligning herself with leading experts in her field and staying abreast of the latest developments in blood cell research. These accolades reflect her respected standing within the scientific community.

🌍 Impact and Influence

Beyond technical expertise, Dr. Glogowska is praised for her team coordination and communication skills, qualities that have enabled her to contribute meaningfully to collaborative research environments. Her scientific efforts in understanding lipid–ion channel interactions in macrophages directly influence the broader field of cardiovascular immunology. By elucidating the role of Piezo1 channels in inflammatory processes, her research provides foundational knowledge that can inspire novel pharmacological interventions.

🔎 Legacy and Future Contributions

Dr. Glogowska continues to strive toward a future where her research leads to medical breakthroughs in inflammation and cardiovascular disease. She is particularly interested in translational science, where laboratory discoveries transition into clinical applications. Her strong background in biotechnology, dentistry, and molecular biology uniquely equips her to explore cross-disciplinary challenges in human health. As she advances, she aims to bridge research with clinical solutions, contributing to a legacy of innovation in life sciences.

Publication

Title: Potentiation of macrophage Piezo1 by atherogenic 7-ketocholesterol
Authors: Edyta Glogowska, Gregor P. Jose, Ana Rita Dias Araújo, Laurent Yvan-Charvet, Éric R. Honoré
Year: 2025

Title: Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development
Authors: Fenja Knoepp, Shariq Abid, Amal Houssaïni, Éric R. Honoré, Serge Adnot
Year: 2025

Title: Pharmacological activation of PIEZO1 in human red blood cells prevents Plasmodium falciparum invasion
Authors: Rakhee Lohia, Benoit Allegrini, Laurence Berry, Éric R. Honoré, Kai Wengelnik
Year: 2023

Title: A machine-learning algorithm integrating baseline serum proteomic signatures predicts exercise responsiveness in overweight males with prediabetes
Authors: Candela Diaz-Canestro, Jiarui Chen, Yan Liu, Michael Andrew Tse, Aimin Xu
Year: 2023

Title: Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects
Authors: Kang Chen, Lai Yee Cheong, Yuan Gao, Hannah Xiaoyan Hui, Aimin Xu
Year: 2022

Title: Author Correction: Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice
Authors: Shengpeng Wang, Shuang Cao, Malika Arhatte, Éric R. Honoré, Stefan Offermanns
Year: (Correction Published) — Likely 2021 or 2022

Title: Piezo1 and Piezo2 foster mechanical gating of K2P channels
Authors: Edyta Glogowska, Malika Arhatte, Franck C. Chatelain, Amanda Jane Patel, Éric R. Honoré
Year: 2021

Title: Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice
Authors: Shengpeng Wang, Shuang Cao, Malika Arhatte, Éric R. Honoré, Stefan Offermanns
Year: 2020

Title: Piezo Ion Channels in Cardiovascular Mechanobiology
Authors: Dominique Douguet, Amanda Jane Patel, Aimin Xu, Paul Michel Vanhoutte, Éric R. Honoré
Year: (Not explicitly stated, likely ~2020 based on context)

Title: TMEM33 regulates intracellular calcium homeostasis in renal tubular epithelial cells
Authors: Malika Arhatte, Gihan S. Gunaratne, Charbel El Boustany, Éric R. Honoré, Amanda Jane Patel
Year: 2019

 

 

✅ Conclusion

Driven by curiosity and guided by precision, Dr. Glogowska continues to make meaningful strides in biomedical research. Her work stands at the intersection of basic science and medical application, with the potential to influence future therapeutic strategies for cardiovascular and inflammatory diseases. With her versatile skill set and visionary approach, she is well-positioned to leave a lasting impact on the scientific and medical communities. As she moves forward, Dr. Glogowska aspires to further bridge laboratory discoveries with clinical innovations, fostering a legacy of scientific excellence and translational breakthroughs.

 

Rong Wang | Oncology | Best Researcher Award

Dr. Rong Wang | Oncology | Best Researcher Award

Dr. Rong Wang, Nanfang Hospital, Southern Medical University, China.

Dr. Rong Wang, a distinguished figure at Nanfang Hospital, Southern Medical University, has built an impressive career that bridges clinical excellence and pioneering research. From her early academic days, she showed a strong commitment to medical science, which translated into impactful professional endeavors in both patient care and research. Her primary focus lies in clinical and translational medicine, where she has made significant contributions through innovative diagnostics, treatment strategies, and interdisciplinary collaboration. Her accolades reflect her dedication, while her influence is evident in the global reach of her work and her role as a mentor and leader in the medical community.

Profile

Orcid

 

🎓 Early Academic Pursuits

Dr. Rong Wang began her academic journey with a strong foundation in medical sciences, reflecting a deep commitment to healthcare from an early stage. Her educational path was marked by excellence, as she pursued rigorous training in clinical medicine and specialized disciplines. Her formative years at esteemed institutions prepared her with a robust understanding of both theoretical and practical dimensions of medical research, setting the stage for a remarkable professional trajectory.

🏥 Professional Endeavors

Currently affiliated with Nanfang Hospital at Southern Medical University, China, Dr. Rong Wang has established herself as a dedicated clinician and researcher. Her work seamlessly integrates patient care with academic inquiry, creating a dynamic synergy between hospital-based practice and medical innovation. Her role at this prestigious institution has enabled her to engage in cutting-edge research, medical education, and multidisciplinary collaborations that enhance both her personal growth and the advancement of the medical field.

🔬 Contributions and Research Focus

Dr. Wang’s research interests are deeply embedded in clinical and translational medicine, particularly focusing on emerging healthcare challenges in China and globally. Her investigations often revolve around innovative diagnostic techniques, treatment protocols, and patient-centered care strategies. With a vision to bridge the gap between laboratory research and bedside application, her contributions have not only enriched scientific literature but also improved therapeutic outcomes.

🏅 Accolades and Recognition

Over the years, Dr. Rong Wang has been the recipient of numerous accolades that reflect her unwavering dedication to medicine and research. Her work has garnered respect from peers and institutions alike, earning her prestigious awards and invitations to speak at national and international conferences. These honors underscore her role as a thought leader and innovator in the field.

🌏 Impact and Influence

Dr. Wang’s influence extends beyond the walls of her hospital. Her research has informed public health policies and contributed to global discourses on health equity and innovation. She actively collaborates with other researchers and healthcare professionals to promote knowledge exchange, medical training, and sustainable healthcare models. Her mentorship has inspired a new generation of researchers and medical practitioners who are carrying forward her legacy of excellence and empathy.

🌟 Legacy and Future Contributions

As she continues to evolve in her career, Dr. Rong Wang remains committed to pioneering research and medical advancement. Her future aspirations include expanding her research on integrative healthcare solutions and influencing healthcare reform through evidence-based policies. Through her persistent efforts, she aims to leave a lasting legacy marked by innovation, compassion, and societal impact.

🧠 Research-Driven Innovation

At the core of Dr. Wang’s professional identity is her relentless pursuit of scientific truth and practical solutions. Her research embodies a spirit of curiosity and a drive to solve complex medical challenges. Whether through publishing in high-impact journals or leading clinical trials, she consistently pushes the boundaries of knowledge, aiming to bring transformative change to patient care and health systems.

publication

  • Title: Establishment and Characterization of a Brain Parenchymal Metastatic Cell Line AlmoR1 Derived From an NSCLC Patient With EGFR‐TKI Resistance
    Authors: Jingyi Wu, Xiangfei Wu, Jing Wang, Guili Feng, Yuhan Wang, Zide Chen, Wei Wang, Rong Wang
    Year: 2025

 

  • Title: Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer
    Authors: Rong Wang, Tadaaki Yamada, Kenji Kita, Hirokazu Taniguchi, Sachiko Arai, Koji Fukuda, Minoru Terashima, Akihiko Ishimura, Akihiro Nishiyama, Azusa Tanimoto, et al.
    Year: 2020

 

🔚 Conclusion

With a future-oriented mindset and an unwavering commitment to advancing healthcare, Dr. Rong Wang stands as a beacon of medical innovation and compassion. Her career is a testament to how scientific research and clinical practice can come together to improve lives and shape the future of medicine. As she continues her journey, her legacy will be defined by her transformative contributions, the people she has inspired, and the advancements she has helped bring to life in the world of healthcare.

Zewen Cheng | Clinical Medicine | Young Scientist Award

Dr. Zewen Cheng | Clinical Medicine | Young Scientist Award

Dr. Zewen Cheng, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine,  China.

Zewen Cheng’s career is a testament to his dedication to thoracic surgery, combining expertise in both Western and Traditional Chinese medicine. His academic excellence, professional experience, and research contributions highlight his unwavering commitment to advancing patient care. As a skilled surgeon and educator, he continues to make a significant impact in the medical community. Moving forward, his focus on innovation and mentorship will ensure that his contributions leave a lasting mark on the field of thoracic surgery, inspiring future generations of medical professionals.

Profile

Scopus

 

🎓 Early Academic Pursuits

Zewen Cheng embarked on his medical journey with a passion for thoracic surgery, earning a Master of Medicine in Thoracic Surgery from Soochow University in Suzhou, China. Graduating in 2019, he dedicated himself to mastering the complexities of thoracic diseases, developing a strong foundation in both clinical and surgical practices. His academic years were marked by rigorous training and an unwavering commitment to patient care, setting the stage for his future contributions to the medical field.

🏥 Professional Endeavors

After completing his degree, Zewen Cheng undertook a comprehensive three-year residency at The First Affiliated Hospital of Soochow University. From July 2019 to June 2022, he refined his expertise in thoracic surgery, gaining invaluable hands-on experience in clinical diagnostics, patient management, and surgical procedures. His tenure in the residency program enabled him to work closely with senior specialists, tackling complex cases and honing his skills. In September 2022, he advanced to the role of Attending Physician at Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, where he seamlessly integrates Western and Traditional Chinese medical treatments to provide holistic patient care.

🔬 Contributions and Research Focus

Zewen Cheng is deeply invested in the evolving landscape of thoracic surgery. His research interests span innovative surgical techniques, minimally invasive procedures, and the integration of Traditional Chinese Medicine (TCM) in thoracic disease management. With proficiency in data analysis software such as R and SPSS, he actively contributes to medical research, utilizing statistical methodologies to enhance clinical decision-making. His work emphasizes the importance of interdisciplinary approaches in improving patient outcomes and advancing the field of thoracic surgery.

🏆 Accolades and Recognition

Throughout his medical career, Zewen Cheng has been recognized for his dedication and expertise in thoracic surgery. Successfully completing the standardized residency training at The First Affiliated Hospital of Soochow University, he demonstrated exceptional skill and commitment to surgical excellence. His fluency in Medical English (CET-6) has enabled him to collaborate effectively with international medical professionals, further expanding his impact within the global medical community.

💪 Impact and Influence

As an Attending Physician, Zewen Cheng plays a crucial role in supervising and training junior doctors, fostering the next generation of thoracic surgeons. His ability to blend traditional and modern medical practices ensures that patients receive comprehensive treatment tailored to their specific needs. His contributions extend beyond direct patient care, as he actively participates in multidisciplinary teams, shaping the future of thoracic surgery through collaborative innovation and knowledge sharing.

🌟 Legacy and Future Contributions

With a strong foundation in both clinical practice and research, Zewen Cheng aspires to push the boundaries of thoracic surgery through continuous learning and innovation. His commitment to integrating Traditional Chinese Medicine with contemporary surgical techniques presents new avenues for patient care and treatment efficacy. Looking ahead, he envisions contributing to groundbreaking research, refining surgical methodologies, and mentoring future medical professionals, leaving a lasting legacy in the field of thoracic surgery.

 

Publication

Title: Exploring the Causal Relationship Between Frailty and Chronic Obstructive Pulmonary Disease: Insights From Bidirectional Mendelian Randomization and Mediation Analysis
Authors: Zewen Cheng, Jian Wu, Chun Xu, Xiaokun Yan
Year: 2025

 

🏆 Conclusion

Zewen Cheng is a strong candidate for the Young Scientist Award, given his clinical expertise, innovative approach to medicine, and commitment to training future surgeons. Strengthening his research impact and expanding international collaborations would further solidify his position as a leading young scientist in thoracic surgery.